| Selling, General & Admin | 11.54 | 12.34 | 18.77 | 19.81 | 15.82 | 7.53 | |
| Research & Development | 15.38 | 18.63 | 18.3 | 30.38 | 21.66 | 11.19 | |
| Operating Expenses | 26.93 | 30.96 | 37.06 | 50.19 | 37.48 | 18.71 | |
| Operating Income | -26.93 | -30.96 | -37.06 | -50.19 | -37.48 | -18.71 | |
| Interest Expense | -0.06 | -0.09 | -0.14 | -0.22 | -0.67 | -1.69 | |
| Interest & Investment Income | 1.84 | 2.55 | 3.62 | 1.78 | 0.8 | - | |
| Other Non Operating Income (Expenses) | -1.07 | -0.99 | -1.27 | 0.25 | 0.61 | 1 | |
| EBT Excluding Unusual Items | -26.22 | -29.49 | -34.86 | -48.37 | -36.75 | -19.41 | |
| Merger & Restructuring Charges | -0.7 | -0.7 | - | - | - | - | |
| Gain (Loss) on Sale of Investments | 1.07 | 0.99 | 1.06 | -0.22 | -0.62 | - | |
| Gain (Loss) on Sale of Assets | -0.02 | - | -0.3 | - | - | - | |
| Asset Writedown | -0.95 | -0.95 | - | - | - | - | |
| Other Unusual Items | - | - | - | - | 0.57 | 0.05 | |
| Pretax Income | -26.82 | -30.16 | -34.1 | -48.59 | -36.79 | -20.1 | |
| Earnings From Continuing Operations | - | -30.16 | -34.1 | -48.59 | -36.79 | -20.1 | |
| Net Income | -26.82 | -30.16 | -34.1 | -48.59 | -36.79 | -20.1 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.1 | |
| Net Income to Common | -26.82 | -30.16 | -34.1 | -48.59 | -36.79 | -20.2 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 2 | 1 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 2 | 1 | 0 | |
| Shares Change (YoY) | 0.14% | -10.14% | -8.96% | 10.80% | 1618.88% | 338.85% | |
| EPS (Basic) | -21.30 | -24.01 | -24.40 | -31.65 | -26.56 | -250.65 | |
| EPS (Diluted) | -21.30 | -24.01 | -24.40 | -31.65 | -26.56 | -250.65 | |
| Free Cash Flow | -24.28 | -24.82 | -32.2 | -39.35 | -32.29 | -18.91 | |
| Free Cash Flow Per Share | -19.29 | -19.76 | -23.04 | -25.63 | -23.30 | -234.61 | |
| EBITDA | -26.19 | -29.64 | -35.71 | -48.84 | -36.8 | -18.5 | |
| D&A For EBITDA | 0.73 | 1.32 | 1.35 | 1.35 | 0.69 | 0.21 | |
| EBIT | -26.93 | -30.96 | -37.06 | -50.19 | -37.48 | -18.71 | |